Irinotecan HCl

CAS: 100286-90-6 
USP
USDMF No. 23522, USFDA  Approved, 
Mexican GMP, Stability Studies In Zone IVB.
1
1
药丸3
药丸3
实验
实验
药丸2
药丸2
人像
人像

PRODUCTS

Back

               

Technical Data

M. Wt

623.139

Molecular Formula

C33H39ClN4O6

CAS Number

100286-90-6

PubChem ID

74990

InChI Key

GURKHSYORGJETM-WAQYZQTGSA-N

Smiles

Cl.CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O

Documents

USDMF No. 23522, USFDA Approved,
Mexican GMP, Stability Studies In Zone IVB.

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

 

Description

Irinotecan hydrochloride (anhydrous) is a hydrochloride obtained by combining irinotecan with one molar equivalent of hydrochloric acid. Used (in the form of its trihydrate) in combination with fluorouracil and leucovorin, for the treatment of patients with metastatic adenocarcinoma of the pancreas after disease progression following gemcitabine-based therapy.

 

Synonym

Irinotecan Hcl; Topotecin; Campto; Camptosar; CPT-11; CPT 11

 

Disclaimer

Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1). 

 

   

         

IrinotecanHCl